With Komodo:

  • Get high-fidelity R&E insights for 265 million unique individuals at the patient level aligned with the 2020 U.S. Census at the state level
  • Model inclusion/exclusion criteria to determine its impact on recruitment diversity, and adjust without impacting clinical endpoints
  • Boost patient pool diversity by 50% with unprecedented views of HCP patient-level demographics
  • Intervene at key points in the patient journey specific to racial and ethnic groups
  • Choose trial sites that will facilitate patient recruitment within underserved and underrepresented populations
WANT TO LEARN MORE?
BE DATA SAVVY

BE DATA SAVVY

BE DATA SAVVY

Nearly one-third (32%) of Clinical Development teams report they do not yet use solutions enhanced with AI, which is essential for the timely identification of patients who are screening-eligible for clinical trials.